Bazedoxifene/colecalciferol

Drug Profile

Bazedoxifene/colecalciferol

Alternative Names: AK R215

Latest Information Update: 03 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alvogen Korea
  • Class Adjuvants; Azepines; Calcium regulators; Cholestenes; Indoles; Osteoporosis therapies; Phenols; Small molecules; Sterols; Vitamin D analogues
  • Mechanism of Action Selective estrogen receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Osteoporosis

Most Recent Events

  • 03 Nov 2017 Chemical structure information added
  • 13 Jul 2017 Phase-I clinical trials in Osteoporosis (In volunteers) in South Korea (unspecified route) (NCT03321318)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top